[ Price : $8.95]
Federal Register notice: FDA determines that Exela Pharma Sciences fentanyl citrate injections, equivalent to 2.5mg/50mL and 5mg/1...[ Price : $8.95]
Federal Register notice: FDA announces that it issued Mirum Pharmaceuticals a priority review voucher for its approved rare pediat...[ Price : $8.95]
Novartis says its Leqvio successfully lowered LDL cholesterol as a monotherapy in the Phase 3 V-MONO trial.[ Price : $8.95]
FDA warns three companies illegally marketing CPAP cleaning/sanitizing devices in the U.S.[ Price : $8.95]
FDA accepts for priority review a Soleno Therapeutics NDA for DCCR (diazoxide choline) for treating Prader-Willi syndrome (PWS) in...[ Price : $8.95]
FDA accepts for priority review a SpringWorks Therapeutics NDA for mirdametinib, an investigational MEK inhibitor for treating ped...[ Price : $8.95]
Liveyon founder and CEO John Kosolcharoen pleads guilty to a felony charge of introducing an unapproved new stem cell product into...[ Price : $8.95]
FDA publishes a guidance describing and clarifying several aspects of the Voluntary Malfunction Summary Reporting program.